{
    "2020-03-10": [
        [
            {
                "time": "2023-10-01",
                "original_text": "FORM 8.3 - ABBVIE INC - Amendment",
                "features": {
                    "keywords": [
                        "Form 8.3",
                        "Amendment",
                        "AbbVie Inc"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "The Zacks Analyst Blog Highlights: Apple, Facebook, AbbVie, Illumina and Freeport-McMoRan",
                "features": {
                    "keywords": [
                        "Zacks Analyst Blog",
                        "Apple",
                        "Facebook",
                        "AbbVie",
                        "Illumina",
                        "Freeport-McMoRan"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "technology",
                        "healthcare",
                        "materials"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "Form 8.3 - Abbvie Plc",
                "features": {
                    "keywords": [
                        "Form 8.3",
                        "Abbvie Plc"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "Insider Buying: The AbbVie Inc. (NYSE:ABBV) Independent Director Just Bought US$253k Worth Of Shares",
                "features": {
                    "keywords": [
                        "Insider Buying",
                        "AbbVie Inc",
                        "Independent Director",
                        "Shares"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}